Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDP HFA Nasal Aerosol in Perennial Allergic Rhinitis
NCT01134705Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in perennial allergic rhinitis (PAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started May 2010; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01134705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134705.